Analytical Validation of a Melanoma Diagnostic Gene Signature Using Formalin-Fixed Paraffin-Embedded Melanocytic Lesions
Authors:
- 27 March 2015
- journal article
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 9 (5) , 407-416
Abstract
These studies were to validate the analytical performance of a gene expression signature that differentiates melanoma and nevi, using RNA expression from 14 signature genes and nine normalization genes that generates a melanoma diagnostic score (MDS). Formalin-fixed paraffin-embedded melanocytic lesions were evaluated in these studies. The overall SD of the assay was determined to be 0.69 MDS units. Individual amplicons within the signature had an average amplification efficiency of 92% and a SD less than 0.5 CT. The MDS was reproducible across a 2000-fold dilution range of input RNA. Melanin, an inhibitor of PCR, does not interfere with the signature. These studies indicate this signature is robust and reproducible and is analytically validated on formalin-fixed paraffin-embedded melanocytic lesions.Keywords
Funding Information
- Myriad Genetic Laboratories
This publication has 14 references indexed in Scilit:
- Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimensBMC Cancer, 2014
- Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsiesBMC Genomics, 2013
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyThe Lancet Oncology, 2011
- Discordance in the histopathologic diagnosis of melanoma at a melanoma referral centerJournal of the American Academy of Dermatology, 2010
- Melanocytic Tumors of Uncertain Malignant PotentialAmerican Journal of Surgical Pathology, 2010
- Analytical Validation of the Oncotype DX Genomic Diagnostic Test for Recurrence Prognosis and Therapeutic Response Prediction in Node-Negative, Estrogen Receptor–Positive Breast CancerClinical Chemistry, 2007
- An improved method for RNA isolation and removal of melanin contamination from melanoma tissue: Implications for tumor antigen detection and amplificationJournal of Immunological Methods, 2006
- Pathology Review of Cases Presenting to a Multidisciplinary Pigmented Lesion ClinicArchives of Dermatology, 2002
- Melanin Binds Reversibly to Thermostable DNA Polymerase and Inhibits Its ActivityBiochemical and Biophysical Research Communications, 2000
- Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologistsHuman Pathology, 1996